Meghmani Organics Annual General Meeting
Meghmani Organics Limited held its 7th Annual General Meeting on September 8, 2026. The meeting concluded successfully with all items of business transacted as proposed.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
7 announcements with these filters
Meghmani Organics Limited held its 7th Annual General Meeting on September 8, 2026. The meeting concluded successfully with all items of business transacted as proposed.
Meghmani Organics Q1 FY27 revenue fell 12% YoY to INR542cr, but consolidated PAT jumped 280% to INR48.2cr on improved margins and operational efficiencies.
Meghmani Organics reported Q1 FY27 consolidated revenue of ₹542.8 Cr, down 12% YoY, while EBITDA grew 46% to ₹97.9 Cr. Performance was driven by improved product mix despite macroeconomic uncertainties.
Meghmani Organics Ltd reported revenue from operations of ₹542.8 Cr (-11.5% YoY) and net profit of ₹48.2 Cr (+279.5% YoY) for Q1 FY27.
Meghmani Organics reported FY26 standalone revenue of ₹2,091cr (up 4% YoY) and EBITDA of ₹228.7cr (up 27% YoY). Strategy focuses on Brazil expansion and Nano-fertilizer growth.
Meghmani Organics reported FY26 consolidated revenue of ₹2,174 Cr, up 5% YoY, with PAT at ₹28.7 Cr. The company is pivoting towards high-margin Crop Nutrition (Nano Urea) and Titanium Dioxide segments.
Meghmani Organics Ltd reported revenue from operations of ₹474.3 Cr (-14.3% YoY) and net profit of ₹8 Cr (-59.6% YoY) for Q4 FY26.